Search results
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 23 hours agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important...
Bhajan Samraat Anup Jalota attends birthday celebration of Anuja Sahai and launches the...
Mid Day· 1 day agoKalyug Ka Krishnansh is a unique and contemporary take on traditional themes, blending the essence...
Emcure Pharmaceuticals' IPO subscription closes today | India Infoline
India Infoline· 9 hours agoOn the third day of bidding, at the time of writing on July 5, 2024 at 12:12 pm, Emcure Pharmaceuticals IPO is witnessing a overall subscription of 8.83 times.
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 3 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Supreme Court To Consider Requests To Review Verdict On Same-Sex Marriage
NDTV· 26 minutes agoThe Supreme Court is scheduled to consider on July 10 a batch of pleas seeking review of its last...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 3 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 4 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 2 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP...
Livemint· 2 days agoEmcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 5 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...